SCHEMBL8314519

SCHEMBL8314519

Cc1cccc(Nc2ncnc3cnc(N[C@H]4CC[C@H](C(=O)N5CCOCC5)CC4)nc23)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 10/20 0.60
ERBB2 P04626 2/20 0.49
HPGD P15428 1/20 0.49
HTT P42858 1/20 0.49
BRAF P15056 2/20 0.47
SYK P43405 3/20 0.46
MAPK10 P53779 2/20 0.46
CCNE1 P24864 1/20 0.46
CDK2 P24941 1/20 0.46
MAPK8 P45983 1/20 0.46
MAPK9 P45984 1/20 0.46
JUN P05412 1/20 0.46
BTK Q06187 1/20 0.45
KDM4E B2RXH2 1/20 0.45
RAB9A P51151 1/20 0.45
KCNH2 Q12809 2/20 0.44
MAPK3 P27361 1/20 0.44
MAPK1 P28482 1/20 0.44
AURKB Q96GD4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8314526 1.00 EGFR (0.60) EGFRERBB2HPGDHTTBRAF
SCHEMBL8315101 0.93 EGFR (0.57) EGFRERBB2HPGDHTTBRAF
SCHEMBL8315098 0.93 EGFR (0.57) EGFRERBB2HPGDHTTBRAF
SCHEMBL8315282 0.90 EGFR (0.60) EGFRERBB2HPGDHTTSYK
SCHEMBL8457941 0.90 EGFR (0.53) EGFRERBB2HPGDHTTBRAF
SCHEMBL8315278 0.90 EGFR (0.60) EGFRERBB2HPGDHTTSYK
SCHEMBL8457936 0.90 EGFR (0.53) EGFRERBB2HPGDHTTBRAF
SCHEMBL8318556 0.89 CSNK2A1 (0.54) EGFRERBB2HPGDHTTBRAF
SCHEMBL8315561 0.88 EGFR (0.46) EGFRERBB2HPGDHTTBRAF
SCHEMBL8315560 0.88 EGFR (0.46) EGFRERBB2HPGDHTTBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779888-B1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM BOEHRINGER INGELHEIM PHARMA (DE) 1999-04-28 EP claimed
EP-0779888-A1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1997-06-25 EP claimed
WO-1996007657-A1 PYRIMIDO[5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1996-03-14 WO claimed
EP-0779888-B1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM BOEHRINGER INGELHEIM PHARMA (DE) 1999-04-28 EP disclosed
US-5707989-A ANTITUMOR AGENTS, INHIBITING SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES DR. KARL THOMAE GMBH (DE) 1998-01-13 US disclosed
EP-0779888-A1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1997-06-25 EP disclosed
WO-1996007657-A1 PYRIMIDO[5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1996-03-14 WO disclosed